Name:
Burkholderia pseudomultivorans Peeters et al. 2014
DSM No.:
105103, Type strain dsm-105103 dsm105103 dsm 105103 Burkholderia pseudomultivorans
Strain designation:
LiPuma AU3207, Vandamme R-48990
Other collection no.
or WDCM no.:
CCUG 62895,LMG 26883
Isolated from:
human sputum, patient with cystic fibrosis
Country:
United States of America
Portland, Oregon
Date of sampling:
22.06.2001
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
History:
<- CCUG; CCUG 62895 <- P. A. R. Vandamme, LMG; Vandamme R-48990 <- J. J. LiPuma, Univ. Michigan, USA; LiPuma AU3207
Genbank accession numbers:
Summary and
additional information:
<- CCUG; CCUG 62895 <- P. A. R. Vandamme, LMG; Vandamme R-48990 <- J. J. LiPuma, Univ. Michigan, USA; LiPuma AU3207. Human sputum, patient with cystic fibrosis; USA, Portland, Oregon. Type strain. Taxonomy/description (19083). Sequence accession no. 16S rRNA gene: HE962386. (Medium 830, 30°C).
Risk group:
2 (classification according to German
TRBA)
Restrictions:
Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz),
Category A1
Supplied as:
| Delivery form | | Prices |
|
| Freeze Dried | | 100,- € |
| Active culture on request | | 240,- € |
| DNA | | 150,- € | |
| Price Category for this culture: 1 |
Freight and handling charges will be added.
See price list.Note: Freight charges for Risk Group 2 microorganisms will apply.
